Feldan Therapeutics

Feldan Therapeutics is a company dedicated to developing therapeutic applications in regenerative medicine based on the Feldan Shuttle platform, a breakthrough peptide-based delivery system allowing introduction of foreign proteins inside cells. The Feldan Shuttle overcomes delivery obstacles in therapeutic context by providing a safe and highly efficient approach that alleviates manipulation complexity and that is associated with low regulatory burden. The Shuttle platform has been successfully used to transfer active nucleases, antibodies and other proteins and transcription factors inside several types of cells. Moreover, preliminary results in rodents suggest that the Shuttle has a promising potential for in vivo applications.